Jump to main content
Jump to site search

Issue 11, 2007
Previous Article Next Article

Targeting neurological disease with RNAi

Author affiliations


The neuroscientific community rapidly adopted RNA interference techniques as an experimental tool for the dissection of gene function in vitro and in animal models of neurological disease in vivo. Here, we discuss recent advances in the biotechnical implementation of siRNA/shRNA-mediated gene silencing focusing on issues of design, delivery and putative detrimental effects. We then summarize the current use of RNAi in targeting neurological disease models and give an outlook on the implementation of this technique in clinical therapy.

Graphical abstract: Targeting neurological disease with RNAi

Back to tab navigation

Publication details

The article was first published on 29 Aug 2007

Article type: Highlight
DOI: 10.1039/B701169E
Citation: Mol. BioSyst., 2007,3, 773-780

  •   Request permissions

    Targeting neurological disease with RNAi

    P. Lingor and M. Bähr, Mol. BioSyst., 2007, 3, 773
    DOI: 10.1039/B701169E

Search articles by author